Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2020 2
2021 3
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation of Antiseizure Medications in Patients With Brain Tumors.
Peters KB, Templer J, Gerstner ER, Wychowski T, Storstein AM, Dixit K, Walbert T, Melnick K, Hrachova M, Partap S, Ullrich NJ, Ghiaseddin AP, Mrgula M. Peters KB, et al. Among authors: hrachova m. Neurology. 2024 Feb 27;102(4):e209163. doi: 10.1212/WNL.0000000000209163. Epub 2024 Jan 30. Neurology. 2024. PMID: 38290092 Review.
Glioblastoma as an age-related neurological disorder in adults.
Kim M, Ladomersky E, Mozny A, Kocherginsky M, O'Shea K, Reinstein ZZ, Zhai L, Bell A, Lauing KL, Bollu L, Rabin E, Dixit K, Kumthekar P, Platanias LC, Hou L, Zheng Y, Wu J, Zhang B, Hrachova M, Merrill SA, Mrugala MM, Prabhu VC, Horbinski C, James CD, Yamini B, Ostrom QT, Johnson MO, Reardon DA, Lukas RV, Wainwright DA. Kim M, et al. Among authors: hrachova m. Neurooncol Adv. 2021 Sep 4;3(1):vdab125. doi: 10.1093/noajnl/vdab125. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34647022 Free PMC article. Review.
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.
Fortin Ensign SP, Gaulin C, Hrachova M, Ruff M, Harahsheh E, Vicenti K, Castro J, Munoz J, Rosenthal A, Mrugala MM. Fortin Ensign SP, et al. Among authors: hrachova m. Curr Treat Options Oncol. 2022 Dec;23(12):1845-1860. doi: 10.1007/s11864-022-01035-2. Epub 2022 Dec 16. Curr Treat Options Oncol. 2022. PMID: 36525238 Review.
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
Jensen LR, Maier AD, Lomstein A, Graillon T, Hrachova M, Bota D, Ruiz-Patiño A, Arrieta O, Cardona AF, Rudà R, Furtner J, Roeckle U, Clement P, Preusser M, Scheie D, Broholm H, Kristensen BW, Skjøth-Rasmussen J, Ziebell M, Munch TN, Fugleholm K, Walter MA, Mathiesen T, Mirian C. Jensen LR, et al. Among authors: hrachova m. Neurosurg Rev. 2022 Oct;45(5):3067-3081. doi: 10.1007/s10143-022-01849-6. Epub 2022 Aug 19. Neurosurg Rev. 2022. PMID: 35984552 Review.
Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.
Vuong HG, Ngo TNM, Le HT, Jea A, Hrachova M, Battiste J, McNall-Knapp R, Dunn IF. Vuong HG, et al. Among authors: hrachova m. Front Oncol. 2022 Mar 18;12:858148. doi: 10.3389/fonc.2022.858148. eCollection 2022. Front Oncol. 2022. PMID: 35371982 Free PMC article.
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
Mirian C, Duun-Henriksen AK, Maier A, Pedersen MM, Jensen LR, Bashir A, Graillon T, Hrachova M, Bota D, van Essen M, Spanjol P, Kreis C, Law I, Broholm H, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Walter MA, Mathiesen T. Mirian C, et al. Among authors: hrachova m. J Nucl Med. 2021 Apr;62(4):507-513. doi: 10.2967/jnumed.120.249607. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859705 Free article.